Eastern Cooperative Oncology Group: Lymphoma trials

The registry lists 18 Lymphoma studies with Eastern Cooperative Oncology Group as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 2 8Phase 3 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell LymphomaActive, not recruitingNCT01415752Phase 2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System LymphomaTerminatedNCT00335140Phase 2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's LymphomaCompletedNCT00274924Phase 2Results posted
• Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell NeoplasmsCompletedNCT00217425Phase 2Results posted
• Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's LymphomaCompletedNCT00075946Phase 3Results posted
• Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell LymphomaTerminatedNCT00070291Phase 2Results posted
• Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaTerminatedNCT00057954Phase 2Results posted
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's LymphomaCompletedNCT00003389Phase 3Results posted
• DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402CompletedNCT01406782
• Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell NeoplasmsCompletedNCT01390597
• Biomarkers in Samples From Patients With Follicular Lymphoma Treated With RituximabCompletedNCT01150643
• Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical TrialCompletedNCT00897767
• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWithdrawnNCT00093678Not applicable
• Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell LymphomaCompletedNCT00052923Phase 3
• Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00003615Phase 2
• Combination Chemotherapy in Treating Patients With AIDS-Related LymphomaCompletedNCT00003388Phase 2
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's LymphomaCompletedNCT00003150Phase 3
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerCompletedNCT00002520Not applicable